Chicago PMI Shows Smaller Than Expected Rebound in June

In May, many US states began to lift restrictions and reopen their economiesso they could get a head-start on that V-shaped recovery everyone was talking about. Now however, some of those US states are only left with skyrocketing coronavirus cases, with a v-shaped recovery nowhere to be found.

According to the Chicago Purchasing Manager’s Index (PMI), which measures the economic wellbeing of Chicago’s manufacturing sector, only a slight rebound from the previous month’s 38 year low was noted in June. Economists polled by Econday predicted the PMI to increase from 32.3 in May to at least 44.5 in June. In reality however, there was only a slight rebound to 36.6.

Some indicators of the Chicago PMI saw improvements, such as New Orders and Production, the largest rebounds for the month. In addition to the reported indices, the Chicago PMI also surveyed respondents on how they plan to proceed with employment levels. According to the manufactures that responded, over half are anticipating a hiring freeze, while another 18% are anticipating a workforce expansion.

Information for this briefing was found via MarketWatch and Trading Economics. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Agnico Q1 Earnings Results Overshadowed By A Sinking Gold Price

Why More People Are Starting to Feel Broke | Darrell Thomas – VRIC Media

Newmont Q1 Earnings: A Billion In Free Cash Flow… A Month!

Recommended

Selkirk Copper Strikes New Lens Beneath Old Pit, Launches 50,000 Metre Phase 2 Program

Silver47 Pulls High-Grade Gold and Silver Assays from Nevada Vein Network At Kennedy

Related News

Bank of America Targets Gold Prices to Reach $3000

The Bank of America has increased its 18-month gold target from $2,000 to $3,000 per...

Tuesday, April 21, 2020, 08:57:24 PM

Revive Therapeutics Granted FDA Approval For Phase 3 Clinical Trial For Bucillamine In COVID-19 Treatment

It’s a big day for Revive Therapeutics (CSE: RVV) (OTC: RVVTF). The company announced this...

Friday, July 31, 2020, 09:16:29 AM

Event Horizon: Bond ETFs on the Edge of the COVID Credit Crunch

Y’all want to see a chart? This one looks like a chart of the output...

Friday, March 27, 2020, 08:34:56 AM

Increase in Rail Shipments Suggests Canadian Economy Beginning to Rebound

Much of Canada’s economy came to a stand-still as the coronavirus pandemic brought about lockdowns,...

Wednesday, June 3, 2020, 04:45:47 PM

Datametrex Awarded Tender To Supply 2,000 COVID-19 Test Kits

Datametrex AI (TSXV: DM) appears to have a sales pipeline in the mining sector. This...

Friday, June 5, 2020, 08:43:21 AM